ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
April 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
Supporting ANS now, for the future
Hash Hashemianpresident@ans.org
From kindergarten classrooms to national security facilities, each event I attended during the opening weeks of the new year underscored one truth: The future of nuclear energy depends on the people we inspire, educate, and empower today.
I had a busy start to 2026, first speaking at the Nashville Energy and Mining Summit alongside Tennessee Electric Cooperative Association senior vice president Justin Maierhofer to explore the necessary synergies among policy, academic coursework, research, and industry expertise in accelerating American nuclear innovation. Drawing on experiences in high-level government relations and public affairs and decades of work in nuclear instrumentation advancements, we discussed Tennessee’s nuclear renaissance, workforce development, and policy frameworks that support emerging energy demands.
Tsutomu Shimura, Yoshikazu Kuwahara, Manabu Fukumoto, Toshiyuki Umata
Fusion Science and Technology | Volume 60 | Number 3 | October 2011 | Pages 1190-1192
Biology | Proceedings of the Ninth International Conference on Tritium Science and Technology | doi.org/10.13182/FST11-A12628
Articles are hosted by Taylor and Francis Online.
Tritium is used as fuel for nuclear fusion reactions and has cancer risk for workers in nuclear fusion plant by its exposure during routine operation or accidents. Tritium exists as tritiated water (HTO) which is produced by an isotope exchange reaction from HT in normal circumstance. In this study we analyzed cellular response against HTO exposure in a human liver cancer cell line HepG2 and a cervical cancer cell line HeLa. These cells were immersed in RPMI medium containing HTO at the dose rate of 0.5 Gy/hr for 20 hrs (10 Gy). We determined whether the DNA-PK/AKT pathway is activated by chronic HTO exposure or not. As well as X-rays, exposure of HepG2 and HeLa cells to HTO activated AKT, which was shown by phosphorylated-AKT at Serine473. The activation of DNA-PK was also observed in these cells by X-ray irradiation but not by exposure to HTO. Instead of DNA-PK, epidermal growth factor receptor and ERK1/2 were activated following HTO exposure. These results suggested that certain cellular molecules are response to HTO exposure. Our study may provide molecular markers to estimate the biological effects in response to tritium exposure in human cells.